WebMD Health Corp. (WBMD) [Rocket]

Overview

WebMD Health Corp. (WBMD)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
09/25/2017	15-12B	Form 15-12B - Securities registration termination [Section 12(b)]:
09/15/2017	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
09/15/2017	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
09/15/2017	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
09/15/2017	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
09/15/2017	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
09/15/2017	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12	Dec-31-11	Dec-31-10	Dec-31-09
Revenues	705.0	636.4	580.4	515.3	469.9	558.8	534.5	438.5
Revenue growth	10.8%	9.6%	12.6%	9.7%	-15.9%	4.5%	21.9%	17.4%
Cost of goods sold	266.7	247.3	224.1	209.7	216.4	201.7	187.8	165.8
Gross profit	438.4	389.1	356.4	305.6	253.5	357.1	346.7	272.8
Gross margin	62.2%	61.1%	61.4%	59.3%	54.0%	63.9%	64.9%	62.2%
Sales and marketing	146.0	138.0	136.2	128.0	127.7	124.3	120.9	112.1
General and administrative	91.1	91.6	94.1	93.2	97.6	91.3	85.5	89.6
EBITA	143.2	101.0	74.3	34.4	-16.2	110.5	91.9	17.5
EBITA margin	20.3%	15.9%	12.8%	6.7%	-3.5%	19.8%	17.2%	4.0%
Amortization of intangibles	3.1	3.3	2.8	2.3	3.9	2.6	3.4	6.3
EBIT	140.0	97.7	71.5	32.1	-20.1	107.9	88.5	11.2
EBIT margin	19.9%	15.4%	12.3%	6.2%	-4.3%	19.3%	16.5%	2.5%
Pre-tax income	146.8	99.9	71.6	28.8	-25.2	110.4	72.3	26.2
Income taxes	55.5	35.8	30.7	13.6	-2.1	46.2	20.0	-45.5
Tax rate	37.8%	35.9%	42.9%	47.4%	8.5%	41.8%	27.7%
Earnings from continuing ops	91.3	64.0	39.8	15.1	-25.8	53.8	50.5	71.7
Earnings from discontinued ops			1.1		2.7	10.4	1.8	49.4
Net income	91.3	64.0	40.9	15.1	-23.1	64.2	52.3	121.0
Net margin	13.0%	10.1%	7.1%	2.9%	-4.9%	11.5%	9.8%	27.6%

Diluted EPS	$1.69	$1.22	$0.87	$0.31	($0.51)	$0.91	$0.81	$1.24
Shares outstanding (diluted)	54.2	52.7	45.6	48.4	50.9	59.1	62.2	57.7

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.